Evidence map›Paper›PMID 33980426›Full record

SynthesisJournal of cardiothoracic and vascular anesthesia2021

Right Ventricular Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis.

Gianluca Paternoster, Pietro Bertini, Pasquale Innelli, Paolo Trambaiolo, Giovanni Landoni, Federico Franchi, Sabino Scolletta, Fabio Guarracino

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of cardiothoracic and vascular anesthesia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Cardiopulmonary Complications after Pulmonary Embolism in COVID-19.International journal of molecular sciences · 2024
    Article
  4. Observational
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Multimodality Cardiac Imaging in COVID.Circulation research · 2023
    Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence.International journal of environmental research and public health · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Gianluca PaternosterDivision of Cardiac Resuscitation, Cardiovascular Anesthesia and Intensive Care, San Carlo Hospital, Potenza, Italy.
Pietro BertiniDepartment of Anesthesia and Critical Care Medicine, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Pasquale InnelliIntensive Coronary Care Unit, Division of Cardiology, San Carlo Hospital, Potenza, Italy.
Paolo TrambaioloIntensive Coronary Care Unit, Sandro Pertini Hospital, Roma, Italy.
Giovanni LandoniDepartment of Anesthesia and Intensive Care, Istituto di Ricerca a Carattere Scientifico, San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.
Federico FranchiDepartment of Medicine, Surgery and Neuroscience, Anesthesia and Intensive Care Unit, University of Siena, Siena, Italy.
Sabino ScollettaDepartment of Medicine, Surgery and Neuroscience, Anesthesia and Intensive Care Unit, University of Siena, Siena, Italy.
Fabio GuarracinoDepartment of Anesthesia and Critical Care Medicine, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Azienda Ospedaliera Universitaria Pisana · ITUniversity of Siena · ITOspedale San Carlo · ITOspedale Sandro Pertini · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis systematic review and meta-analysis aimed to describe the features of right ventricular impairment and pulmonary hypertension in coronavirus disease (COVID-19) and assess their effect on mortality.

designThe authors carried out a systematic review and meta-analysis of observational studies.

settingThe authors performed a search through PubMed, the International Clinical Trials Registry Platform, and the Cochrane Library for studies reporting right ventricular dysfunction in patients with COVID-19 and outcomes.

participantsThe search yielded nine studies in which the appropriate data were available.

interventionsPooled odds ratios were calculated according to the random-effects model. MEASUREMENTS AND MAIN

resultsOverall, 1,450 patients were analyzed, and half of them were invasively ventilated. Primary outcome was mortality at the longest follow-up available. Mortality was 48.5% versus 24.7% in patients with or without right ventricular impairment (n = 7; OR = 3.10; 95% confidence interval [CI] 1.72-5.58; p = 0.0002), 56.3% versus 30.6% in patients with or without right ventricular dilatation (n = 6; OR = 2.43; 95% CI 1.41-4.18; p = 0.001), and 52.9% versus 14.8% in patients with or without pulmonary hypertension (n = 3; OR = 5.75; 95% CI 2.67-12.38; p < 0.001).

conclusionMortality in patients with COVID-19 requiring respiratory support and with a diagnosis of right ventricular dysfunction, dilatation, or pulmonary hypertension is high. Future studies should highlight the mechanisms of right ventricular derangement in COVID-19, and early detection of right ventricular impairment using ultrasound might be important to individualize therapies and improve outcomes.

Indexed as

COVID-19Hypertension, PulmonaryVentricular Dysfunction, RightHeart VentriclesHumansSARS-CoV-2ARDSCOVID-19critical careechocardiographymeta-analysisright ventricle

Identifiers

PMID33980426
PMCPMC8038863
OpenAlexW3154440411

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.